News Chart MiNK Therapeutics, Inc.

Equities

INKT

US6036931029

Market Closed - Nasdaq Other stock markets 21:30:00 07/06/2024 BST			5-day change	1st Jan Change
0.9642 ^USD	-1.61%		-0.59%	-9.88%

05-22	MiNK Therapeutics, Inc. Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting	CI
05-14	Transcript : MiNK Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024

25a304f7e488cf.DaZp-jdxKp7qoDuRQV2cBPNvMSBSHFd388J_uCKgRDM.We8MzgMgB--O8mjkMB_9NoojehkleAEAhJI3yE_5A1BXzjGybiFw15nXAw~3038936811c9b27cb19062605974b578